Dec 20, 2017 | Press & Recognition
Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Their therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly...
Jun 7, 2017 | Press & Recognition
America’s Biopharmaceutical Companies and Austin Community College’s Bioscience Incubator (ABI) are excited to host a panel discussion on Monday, June 12, “Texas Leads in Biotech,” in partnership with the Texas Tribune that will focus on innovation in the...
May 9, 2017 | Press & Recognition
Curtana Pharmaceuticals is developing highly targeted therapies for the treatment of brain cancer, including glioblastoma in adults and pediatric high grade glioma in children. Patients typically are treated with surgery, radiation, and chemotherapy. Unfortunately,...
May 9, 2017 | Press & Recognition
IsoStem, Inc. is an Austin-based biotech company commercializing a proprietary bone marrow autograft concentration system that is not only automated and disposable, but also reduces the risk of infections and complications during medical procedures by eliminating the...
Mar 1, 2017 | Press & Recognition
Celling Biosciences is advancing the future of medicine through the innovation of point-of-care, autologous regenerative cell therapies. Their dedicated team of scientists, engineers and physicians are focused on developing point-of-care systems, innovative surgical...
